insulin lispro protamine and insulin lispro (Humalog Mix 50/50)
insulin lispro protamine and insulin lispro is an FDA-licensed reference biologic from Eli Lilly and Company. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1999
Reference approved
Reference product
Humalog Mix 50/50 insulin lispro protamine and insulin lispro
Eli Lilly and Company
- Approved
- Dec 22, 1999
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for insulin lispro protamine and insulin lispro, in chronological order.
Reference approval
Approval date of the reference insulin lispro protamine and insulin lispro product.
26 yr 10 mo ago
Frequently asked questions
Are there biosimilars approved for insulin lispro protamine and insulin lispro (Humalog Mix 50/50)?
No 351(k) biosimilars or interchangeable biosimilars referencing insulin lispro protamine and insulin lispro are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.